HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Marion Webb

Managing Editor

San Diego, CA

Marion Webb has been writing about health care issues for nearly two decades as a full-time reporter and freelancer. As the senior business reporter for the San Diego Business Journal, Marion covered new medical innovations at San Diego’s top-ranking research institutions and the medical device and life sciences industry for nearly eight years. She’s also been a regular contributor to the Los Angeles County Medical Association’s Physician Magazine and Physicians News Network focusing on new technologies, practice management, reimbursement and other trendy issues relevant to physician practices and their ability to succeed. She remains fascinated by the ever-growing numbers of innovative products coming out of the medtech sector, from potentially life-saving devices to help treat patients who otherwise wouldn’t have access to medical care to breakthrough technologies that benefit mankind. Marion earned her BA in communications from UC San Diego and continues to enjoy an active lifestyle in San Diego.

Set Alert for Articles By Marion Webb

Latest From Marion Webb

Market Brief: New Triple-Combination Therapies Help Boost Lackluster Inhalation Devices Market

The inhalation devices market will reach $12bn by 2023, driven by the rising prevalence of asthma and COPD worldwide. GlaxoSmithKline, AstraZeneca and Boehringer Ingelheim dominate worldwide sales of inhalation products for asthma and COPD, and are facing generic competition. Generics developers and major pharma players are trying to set themselves apart with better drug-delivery devices. 

Market Intelligence Respiratory

Market Brief: Innovation Will Drive 13% Growth In Global Transcatheter Mitral Valve Repair Market by 2023, Outpacing Growth Of TAVR

The transcatheter heart valve management products market will reach $6.7bn by 2023, driven by the rising prevalence of heart disease. Transcatheter aortic valve replacement (TAVR) procedures lead the market, but innovation and rising competition, including from companies in China and India, will fuel double-digit growth in the much smaller mitral valve repair market, dominated by Abbott's MitraClip.

Market Intelligence Innovation

Recipharm Boosts Inhalation And Injectables Manufacturing By Acquiring UK’s Consort Medical

Sweden's Recipharm has agreed to buy UK-based Consort Medical for £505m ($652m) to become a leading inhalation-device company. 

Deals Manufacturing

Roundup: XMed2019: 7 Innovators To Watch

Medtech Insight features its shortlist of top innovators who showcased their products at the recent Exponential Medicine conference in San Diego.

Artificial Intelligence Digital Health

Device Week, 14 November 2019 – Medtech Leaders Look To The Future At XMed 2019; Abbott Names New CEO

In this week's podcast, Medtech Insight managing editor Marion Webb summarizes her recent interviews with Ted Tanner, CTO of IBM Watson Health, and Catherine Mohr, president of the Intuitive Foundation, during the Exponential Medicine conference in San Diego. And deputy editor Reed Miller discusses the appointment of Robert Ford as the new CEO of Abbott Laboratories, the latest in a recent series of high-profile CEO appointments in medtech.

Device Week Artificial Intelligence

Exec Chat: XMed2019: How IBM Watson Health's CTO Uses Blockchain To Eliminate 'Friction Points' In Health Care

Ted Tanner, the new chief technology officer and chief architect of IBM Watson Health, recently sat down with Medtech Insight to discuss his plans for the company. In 2020, IBM will start testing the first use cases of its blockchain-based data information exchange network, a partnership with several health-care organizations, aimed at reducing administrative errors and costs. Tanner refers to blockchain as an "enablement platform" that augments computing power.

Exec Chat Artificial Intelligence
See All
UsernamePublicRestriction

Register